NCT05868837 2025-08-01
REFINE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 3 Recruiting
Clinical Trials
7 trialsNCT07071246 2025-07-17
Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis
Tang-Du Hospital
Phase NA Active not recruiting
NCT02950155 2024-10-26
Rinomax
Karolinska Institutet
Phase 3 Completed
NCT05332587 2022-05-02
Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis
First Affiliated Hospital, Sun Yat-Sen University
Phase 3 Unknown
NCT02110706 2020-03-06
BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis
Yale University
Phase 2 Completed
NCT00619671 2013-01-16
A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
University of Vermont
Phase 1/2 Completed
NCT00774462 2012-12-11
FORCE
Assistance Publique - Hôpitaux de Paris
Phase 2 Completed